RU2001128504A - Growth promoting compositions - Google Patents

Growth promoting compositions

Info

Publication number
RU2001128504A
RU2001128504A RU2001128504/14A RU2001128504A RU2001128504A RU 2001128504 A RU2001128504 A RU 2001128504A RU 2001128504/14 A RU2001128504/14 A RU 2001128504/14A RU 2001128504 A RU2001128504 A RU 2001128504A RU 2001128504 A RU2001128504 A RU 2001128504A
Authority
RU
Russia
Prior art keywords
inhibitor
dipeptidyl peptidase
dwarfism
composition
pharmaceutical composition
Prior art date
Application number
RU2001128504/14A
Other languages
Russian (ru)
Other versions
RU2242228C2 (en
Inventor
Пьер БРОКА
Original Assignee
Ферринг Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9906715.9A external-priority patent/GB9906715D0/en
Application filed by Ферринг Б.В. filed Critical Ферринг Б.В.
Publication of RU2001128504A publication Critical patent/RU2001128504A/en
Application granted granted Critical
Publication of RU2242228C2 publication Critical patent/RU2242228C2/en

Links

Claims (10)

1. Фармацевтическая композиция, предназначенная для лечения замедленного роста или карликовости, отличающаяся тем, что она включает в себя терапевтически эффективное количество ингибитора дипептидилпептидазы IV.1. A pharmaceutical composition for treating stunted growth or dwarfism, characterized in that it comprises a therapeutically effective amount of a dipeptidyl peptidase IV inhibitor. 2. Композиция по п.1, в которой замедленный рост или карликовость связаны с недостатком гормона роста.2. The composition according to claim 1, in which slow growth or dwarfism is associated with a lack of growth hormone. 3. Фармацевтическая композиция, предназначенная для стимуляции восстановления тканей, отличающаяся тем, что она включает в себя терапевтически эффективное количество ингибитора дипептидилпептидазы IV.3. A pharmaceutical composition intended to stimulate tissue repair, characterized in that it comprises a therapeutically effective amount of a dipeptidyl peptidase IV inhibitor. 4. Композиция по любому из предшествующих пунктов, в которой ингибитор дипептидилпептидазы IV содержит нитрил аминоацилпирролидина.4. A composition according to any one of the preceding claims, wherein the dipeptidyl peptidase IV inhibitor comprises aminoacylpyrrolidine nitrile. 5. Композиция по любому из предшествующих пунктов, которая изготовлена для перорального применения.5. The composition according to any one of the preceding paragraphs, which is made for oral use. 6. Композиция по п.5, изготовленная в виде таблетки или капсулы.6. The composition according to claim 5, made in the form of tablets or capsules. 7. Применение ингибитора дипептидилпептидазы IV для приготовления терапевтической композиции для лечения замедленного развития или карликовости или для стимуляции регенерации тканей.7. The use of a dipeptidyl peptidase IV inhibitor for the preparation of a therapeutic composition for the treatment of delayed development or dwarfism or for stimulating tissue regeneration. 8. Способ лечения замедленного развития или карликовости, при котором пациенту вводят фармацевтическую композицию, содержащую ингибитор дипептидилпептидазы IV.8. A method of treating delayed development or dwarfism, in which a pharmaceutical composition comprising a dipeptidyl peptidase IV inhibitor is administered to a patient. 9. Способ по п.8, при котором композицию вводят один раз в день, вечером.9. The method of claim 8, wherein the composition is administered once a day, in the evening. 10. Способ регенерации ткани, при котором пациенту вводят фармацевтическую композицию, содержащую ингибитор дипептидил-пептидазы IV.10. A tissue regeneration method in which a pharmaceutical composition comprising a dipeptidyl peptidase IV inhibitor is administered to a patient.
RU2001128504/15A 1999-03-23 2000-03-21 Growth-stimulating composition RU2242228C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9906715.9 1999-03-23
GBGB9906715.9A GB9906715D0 (en) 1999-03-23 1999-03-23 Compositions for promoting growth

Publications (2)

Publication Number Publication Date
RU2001128504A true RU2001128504A (en) 2003-06-27
RU2242228C2 RU2242228C2 (en) 2004-12-20

Family

ID=10850230

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001128504/15A RU2242228C2 (en) 1999-03-23 2000-03-21 Growth-stimulating composition

Country Status (26)

Country Link
US (1) US6521644B1 (en)
EP (1) EP1171121B1 (en)
JP (1) JP2002539244A (en)
KR (1) KR100704348B1 (en)
CN (1) CN1359293A (en)
AR (1) AR023130A1 (en)
AT (1) ATE297728T1 (en)
AU (1) AU772421B2 (en)
CA (1) CA2366926A1 (en)
CZ (1) CZ20013411A3 (en)
DE (1) DE60020825T2 (en)
GB (1) GB9906715D0 (en)
HK (1) HK1048589A1 (en)
HU (1) HUP0200391A3 (en)
IL (2) IL145568A0 (en)
MX (1) MXPA01009610A (en)
MY (1) MY124214A (en)
NO (1) NO20014608L (en)
NZ (1) NZ514450A (en)
PL (1) PL195529B1 (en)
RU (1) RU2242228C2 (en)
TR (1) TR200102648T2 (en)
TW (1) TWI239246B (en)
UA (1) UA73115C2 (en)
WO (1) WO2000056297A2 (en)
ZA (1) ZA200108082B (en)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040152745A1 (en) * 1999-11-12 2004-08-05 Guilford Pharmaceuticals, Inc. Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors
GB9928330D0 (en) 1999-11-30 2000-01-26 Ferring Bv Novel antidiabetic agents
US6395767B2 (en) 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
JP4300108B2 (en) * 2001-06-27 2009-07-22 スミスクライン ビーチャム コーポレーション Pyrrolidines as dipeptidyl peptidase inhibitors
UA74912C2 (en) 2001-07-06 2006-02-15 Merck & Co Inc Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
CA2508487A1 (en) * 2002-12-04 2004-06-17 Merck & Co., Inc. Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
CA2518465A1 (en) * 2003-03-25 2004-10-14 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
EP1625122A1 (en) 2003-05-14 2006-02-15 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
US7169926B1 (en) 2003-08-13 2007-01-30 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7678909B1 (en) 2003-08-13 2010-03-16 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
CN1867560A (en) * 2003-08-13 2006-11-22 武田药品工株式会社 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
EP1697342A2 (en) * 2003-09-08 2006-09-06 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
EP1699777B1 (en) * 2003-09-08 2012-12-12 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
UA85871C2 (en) * 2004-03-15 2009-03-10 Такеда Фармасьютікал Компані Лімітед Dipeptidyl peptidase inhibitors
WO2005118555A1 (en) * 2004-06-04 2005-12-15 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
WO2006019965A2 (en) 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
US7872124B2 (en) * 2004-12-21 2011-01-18 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
DOP2006000008A (en) 2005-01-10 2006-08-31 Arena Pharm Inc COMBINED THERAPY FOR THE TREATMENT OF DIABETES AND RELATED AFFECTIONS AND FOR THE TREATMENT OF AFFECTIONS THAT IMPROVE THROUGH AN INCREASE IN THE BLOOD CONCENTRATION OF GLP-1
CA2599419A1 (en) * 2005-04-22 2006-11-02 Alantos Pharmaceuticals Holding, Inc. Dipeptidyl peptidase-iv inhibitors
CN102908350B (en) * 2005-09-14 2014-07-23 武田药品工业株式会社 Dipeptidyl peptidase inhibitors for treating diabetes
NZ566799A (en) 2005-09-14 2011-04-29 Takeda Pharmaceutical Dipeptidyl peptidase inhibitors for treating diabetes
US20070060529A1 (en) * 2005-09-14 2007-03-15 Christopher Ronald J Administration of dipeptidyl peptidase inhibitors
TW200745079A (en) * 2005-09-16 2007-12-16 Takeda Pharmaceuticals Co Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
WO2007035629A2 (en) 2005-09-16 2007-03-29 Takeda Pharmaceutical Company Limited Process for the preparation of pyrimidinedione derivatives
TW200745080A (en) * 2005-09-16 2007-12-16 Takeda Pharmaceuticals Co Polymorphs of tartrate salt of 2-[2-(3-(R)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6H-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
EP1999108A1 (en) * 2006-03-28 2008-12-10 Takeda Pharmaceutical Company Limited Preparation of (r)-3-aminopiperidine dihydrochloride
PE20071221A1 (en) 2006-04-11 2007-12-14 Arena Pharm Inc GPR119 RECEPTOR AGONISTS IN METHODS TO INCREASE BONE MASS AND TO TREAT OSTEOPOROSIS AND OTHER CONDITIONS CHARACTERIZED BY LOW BONE MASS, AND COMBINED THERAPY RELATED TO THESE AGONISTS
SI2073810T1 (en) * 2006-09-13 2011-12-30 Takeda Pharmaceutical Use of 2-6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl-4-fluoro-benzonitrile for treating diabetes, cancer, autoimmune disorders and hiv infection
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) * 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
EP2146210A1 (en) 2008-04-07 2010-01-20 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
JO2870B1 (en) 2008-11-13 2015-03-15 ميرك شارب اند دوهم كورب Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
AR077642A1 (en) 2009-07-09 2011-09-14 Arena Pharm Inc METABOLISM MODULATORS AND THE TREATMENT OF DISORDERS RELATED TO THE SAME
EP2473047B1 (en) 2009-09-02 2014-08-13 Merck Sharp & Dohme Corp. Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
JP5540454B2 (en) 2009-12-30 2014-07-02 シャンハイ フォチョン ファーマシューティカル カンパニー リミテッド Dipeptidyl peptidase inhibitor
EP2538783B1 (en) 2010-02-22 2016-06-01 Merck Sharp & Dohme Corp. Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
EP2556056A1 (en) 2010-04-06 2013-02-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2011146358A1 (en) 2010-05-21 2011-11-24 Merck Sharp & Dohme Corp. Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
KR101871011B1 (en) 2010-09-22 2018-06-25 아레나 파마슈티칼스, 인크. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012135570A1 (en) 2011-04-01 2012-10-04 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145361A1 (en) 2011-04-19 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145603A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145604A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
EP2814485A4 (en) 2012-02-17 2015-08-26 Merck Sharp & Dohme Dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
EP2874622A4 (en) 2012-07-23 2015-12-30 Merck Sharp & Dohme Treating diabetes with dipeptidyl peptidase-iv inhibitors
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
EA201791982A1 (en) 2015-03-09 2020-02-17 Интекрин Терапьютикс, Инк. METHODS FOR TREATING A NON-ALCOHOLIC FAT LIVER DISEASE AND / OR LIPODYSTROPHY
CN110996951A (en) 2017-04-03 2020-04-10 科赫罗斯生物科学股份有限公司 PPAR gamma agonists for the treatment of progressive supranuclear palsy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05508624A (en) 1990-04-14 1993-12-02 ニュー　イングランド　メデカル　センター　ホスピタルズ　インク Dipeptidyl-aminopeptidase type 4 inhibitor
WO1992008481A1 (en) * 1990-11-14 1992-05-29 The Upjohn Company Stabilized, potent grf analogs
JPH0543453A (en) * 1991-08-20 1993-02-23 Sumitomo Pharmaceut Co Ltd Local sustained-release preparation for accelerating wound curing
HUT67319A (en) * 1991-08-30 1995-03-28 Life Medical Sciences Inc Compositions for treating wounds
DK0610317T3 (en) * 1991-10-22 2001-02-19 New England Medical Center Inc Inhibitors of dipeptidyl aminopeptidase type IV
IL111785A0 (en) * 1993-12-03 1995-01-24 Ferring Bv Dp-iv inhibitors and pharmaceutical compositions containing them
JPH09295946A (en) * 1995-05-16 1997-11-18 Mitsui Pharmaceut Inc Medicine composition
JPH09308259A (en) * 1996-05-17 1997-11-28 Toshiba Lighting & Technol Corp Power supply, discharge lamp lighting apparatus and lighting apparatus
TW492957B (en) * 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
US5952301A (en) 1996-12-10 1999-09-14 1149336 Ontario Inc. Compositions and methods for enhancing intestinal function

Similar Documents

Publication Publication Date Title
RU2001128504A (en) Growth promoting compositions
RU2001128507A (en) Fertility Improving Compositions
WO2003073981A3 (en) Novel of cytokine inhibitors
IL189546A0 (en) Therapy for the treatment of disease
CA2366911A1 (en) Compositions for improving fertility
WO2005081742A3 (en) Testosterone oral dosage formulations and associated methods
HK1076379A1 (en) Use of a composition comprising anti-vla-1 antibody for the preparation of a pharmaceutical composition for the treatment of pulmonary fibrosis
TWI367751B (en) Pharmaceutical composition comprising rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
WO2005058233A3 (en) Methods for treatment of acute pancreatitis
RU2004135563A (en) MEDICINE FOR TREATING AN INCREASED ACTIVITY OF THE BLADDER
SE0400184D0 (en) New therapeutic use
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
JP2005507892A5 (en)
HK1034446A1 (en) Therapeutic agents.
CA2534577A1 (en) Method for promoting bone growth
PT1677806E (en) Methods for treating acute and overuse sprain and strain using hyaluronic acid
WO2000057867A3 (en) Improved cancer treatment with temozolomide
NZ594154A (en) Transdermal administration of buprenorphine for preoperative treatment of post operative pain
MXPA01012936A (en) Pharmaceutical composition containing sibutramine and orlistat.
JP2005501108A5 (en)
SE0200598D0 (en) Pharmaceutical composition and method of treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and / or ischemic consequences
WO2004073627A3 (en) Novel therapeutic method and compositions for topical administration
RU2002122703A (en) METHOD FOR TREATING INFLAMMATORY AND INFLAMMATORY DESTRUCTIVE PERIODONTAL DISEASES
HRP20050281A2 (en) Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes
MD1469G2 (en) Method of treatment of the burn shock